Anti-elongation factor-1α autoantibody in adult atopic dermatitis patients

被引:24
作者
Ohkouchi, K
Mizutani, H
Tanaka, M
Takahashi, M
Nakashima, K
Shimizu, W
机构
[1] Mie Univ, Fac Med, Dept Dermatol, Tsu, Mie 5148507, Japan
[2] Mie Univ, Fac Med, Dept Biochem, Tsu, Mie 5148507, Japan
关键词
allergen; allergy; autoimmunity; erythematosus; exanthema;
D O I
10.1093/intimm/11.10.1635
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Adult atopic dermatitis (AD) patients develop severe facial lesions, which sometimes distribute in sun-exposed areas similar to the rash of systemic lupus erythematosus, To declare autoimmunity in the pathogenesis of AD, we investigated serum antinuclear antibody (ANA) in 256 adult AD patients and identified its ligands, A high titer of ANA was found in 31.3% of AD patients and 75% of the ANA showed a homogenous pattern. Sixty-five percent of ANA(+) sera reacted to a 52 kDa protein (p52) in HeLa cell immunoblots, By screening the HeLa cell cDNA expression library with anti-p52 sera, a clearly positive clone was isolated. The sequence of this cDNA was identical to human elongation factor (hEF)-1 alpha. The eluate of IgG bound to hEF-1 alpha-glutathione S-transferase (GST) fusion protein recognized a band at 52 kDa in a HeLa cell immunoblot, and stained Hep-2 cell nuclei and cytoplasma as reported in hEF-1 alpha distribution. The anti-p52 AD sera recognized the hEF-1 alpha-GST fusion protein. The anti-hEF-1 alpha antibody-positive AD patients were characterized by higher facial involvement and lower white blood cell counts compared with antibody-negative patients. The present results suggest the possible involvement of autoimmunity in the pathogenesis of adult AD.
引用
收藏
页码:1635 / 1640
页数:6
相关论文
共 21 条
[1]  
[Anonymous], ACTA DERM VENERE S92, DOI [10.2340/00015555924447, DOI 10.2340/00015555924447]
[2]   Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis [J].
BerthJones, J ;
GrahamBrown, BAC ;
Marks, B ;
Camp, RDR ;
English, JSC ;
Freeman, K ;
Holden, CA ;
Rogers, SCF ;
Oliwiecki, S ;
Friedmann, PS ;
LewisJones, MS ;
Archer, CB ;
Adriaans, B ;
Douglas, WS ;
Allen, BR .
BRITISH JOURNAL OF DERMATOLOGY, 1997, 136 (01) :76-81
[3]   CYCLOSPORINE-A IN SEVERE, THERAPY-RESISTANT ATOPIC-DERMATITIS - REPORT OF AN INTERNATIONAL WORKSHOP, APRIL 1993 [J].
CAMP, RDR ;
REITAMO, S ;
FRIEDMANN, PS ;
HO, V ;
HEULE, F .
BRITISH JOURNAL OF DERMATOLOGY, 1993, 129 (02) :217-220
[4]   Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [J].
Hochberg, MC .
ARTHRITIS AND RHEUMATISM, 1997, 40 (09) :1725-1725
[5]  
Hollingsworth Peter N., 1996, P74, DOI 10.1016/B978-044482383-0/50013-3
[6]  
IMAI S, 1987, HAUTARZT, V38, P599
[7]   RETROPSEUDOGENES CONSTITUTE THE MAJOR PART OF THE HUMAN ELONGATION FACTOR-1-ALPHA-GENE FAMILY [J].
MADSEN, HO ;
POULSEN, K ;
DAHL, O ;
CLARK, BFC ;
HJORTH, JP .
NUCLEIC ACIDS RESEARCH, 1990, 18 (06) :1513-1516
[8]  
PACHMAN LM, 1995, SAMTERS IMMUNOLOGICA, P791
[9]  
Peng Stanford L., 1996, P774, DOI 10.1016/B978-044482383-0/50119-9
[10]   ANTINUCLEAR ANTIBODIES DURING PSORALENS PLUS ULTRAVIOLET-A (PUVA) THERAPY - ARE THEY WORTHWHILE [J].
PICASCIA, DD ;
ROTHE, M ;
GOLDBERG, NS ;
ROENIGK, HH .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1987, 16 (03) :574-577